Endomucin prevents leukocyte–endothelial cell adhesion and has a critical role under resting and inflammatory conditions by Zahr, Alisar et al.
Endomucin prevents leukocyte–endothelial
cell adhesion and has a critical role under
resting and inflammatory conditions
The Harvard community has made this
article openly available.  Please share  how
this access benefits you. Your story matters
Citation Zahr, A., P. Alcaide, J. Yang, A. Jones, M. Gregory, N. G. dela Paz, S.
Patel-Hett, et al. 2016. “Endomucin prevents leukocyte–endothelial
cell adhesion and has a critical role under resting and inflammatory
conditions.” Nature Communications 7 (1): 10363. doi:10.1038/
ncomms10363. http://dx.doi.org/10.1038/ncomms10363.
Published Version doi:10.1038/ncomms10363
Citable link http://nrs.harvard.edu/urn-3:HUL.InstRepos:26318644
Terms of Use This article was downloaded from Harvard University’s DASH
repository, and is made available under the terms and conditions
applicable to Other Posted Material, as set forth at http://
nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-
use#LAA
ARTICLE
Received 17 Mar 2015 | Accepted 3 Dec 2015 | Published 2 Feb 2016
Endomucin prevents leukocyte–endothelial cell
adhesion and has a critical role under resting and
inﬂammatory conditions
Alisar Zahr1,*, Pilar Alcaide2,*,w, Jinling Yang1,*, Alexander Jones1, Meredith Gregory1, Nathaniel G. dela Paz1,
Sunita Patel-Hett1, Tania Nevers2,w, Adarsha Koirala1, Francis W. Luscinskas2, Magali Saint-Geniez1,
Bruce Ksander1, Patricia A. D’Amore1,3 & Pablo Argu¨eso1
Endomucin is a membrane-bound glycoprotein expressed luminally by endothelial cells that
line postcapillary venules, a primary site of leukocyte recruitment during inﬂammation. Here
we show that endomucin abrogation on quiescent endothelial cells enables neutrophils to
adhere ﬁrmly, via LFA-1-mediated binding to ICAM-1 constitutively expressed by endothelial
cells. Moreover, TNF-a stimulation downregulates cell surface expression of endomucin
concurrent with increased expression of adhesion molecules. Adenovirus-mediated
expression of endomucin under inﬂammatory conditions prevents neutrophil adhesion in vitro
and reduces the inﬁltration of CD45þ and NIMP-R14þ cells in vivo. These results indicate
that endomucin prevents leukocyte contact with adhesion molecules in non-inﬂamed tissues
and that downregulation of endomucin is critical to facilitate adhesion of leukocytes into
inﬂamed tissues.
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A
primary function of the endothelium in the non-inﬂamed
steady state is to maintain an anti-adhesive surface by
regulating and inhibiting coagulation, and by resisting the
adhesion of blood leukocytes1–4. It is well documented that
activation of the endothelium in response to injury or infection
leads to the upregulation of adhesion molecules and chemokines
that localize the recruitment of blood leukocytes to speciﬁc tissues
and organs5,6. Postcapillary venules, with their low laminar shear
stress and sparse mural cell investment, are the primary site for
the recruitment of leukocytes7,8. This response is comprised of a
cascade of distinct sequential events including leukocyte tethering
and rolling, ﬁrm adhesion and transmigration6.
The majority of the work conducted to understand the
molecular regulation of leukocyte–endothelial interactions has
focused on adhesion molecules and chemokines responsible for
recruitment of leukocytes to the activated endothelium. These
include E-selectin and P-selectin, which interact with P-selectin
glycoprotein ligand 1 (PSGL1) and other glycosylated ligands on
leukocytes; VCAM-1, which binds to very late antigen 4 (VLA4;
also known as a4b1-integrin); and ICAM-1, which interacts with
lymphocyte function-associated antigen 1 (LFA-1; also known as
aLb2-integrin)9. Cytokines, bacterial endotoxins, hemodynamic
factors and viruses predispose the surface endothelium to local
thrombosis, loss of vessel barrier function and leukocyte
recruitment. In vitro and in vivo studies have illustrated that
leukocyte adhesion and crawling is initiated by activation of the
endothelium by cytokines such as tumour necrosis factor alpha
(TNF-a), interleukin-1 alpha and beta (IL-1a,b) and interferon
gamma (IFN-g)10. In contrast to adhesion molecules, much less
attention has been focused on molecules that might prevent
adhesive tethering of leukocytes or modulate their rolling without
adhesion. This is particularly important since ICAM-1 is
expressed on quiescent or ‘non’-activated endothelial cells1,11.
Glycoproteins in the endothelial glycocalyx have been shown to
block adhesion of blood cells12. The endothelial glycocalyx
is a negatively charged, organized meshwork composed of
proteoglycans and their negatively charged glycosaminoglycans,
glycoproteins bearing terminal sialic acids and associated plasma
proteins13. Heparan sulfate proteoglycans, which comprise
50–90% of the surface glycosaminoglycans, are cleaved as part
of the response to inﬂammation14, presumably to facilitate the
association of leukocytes with the endothelial surface15,16.
Sialomucins, such as CD34—a marker of vascular endothelial
cells—or CD43 on leukocytes, have been shown to both support
and prevent cell adhesion either by increasing or decreasing
surface expression, or by post-translational modiﬁcation, which
allows controlled O-linked glycosylation17,18.
Endomucin (EMCN) is a type I integral membrane
O-sialoglycoprotein expressed on the surface of endothelium in
venules and capillaries, but not on arterial endothelium of
adult tissues19,20. The deduced protein sequence of both human
and mouse EMCN long splice variant has 261 amino acid
residues with an extracellular domain rich in serine and threonine
residues21,22. O-Glycans attached to these residues are important
for maintaining the highly extended and rigid structure of the
protein, as clustered O-glycans induce the peptide core to adopt a
stiff and extended conformation that prevents folding into a
globular structure23, which has an important role in regulating
cell–cell and cell–matrix interactions. In the present study, we
identify a function of EMCN in resisting the adhesion of blood
leukocytes. Mechanistically, we demonstrate that expression
of EMCN opposes the binding of neutrophils to constitutively
expressed ICAM-1 on non-activated endothelial cells. Moreover,
we ﬁnd that inﬂammatory cytokines decrease EMCN expression,
and that overexpression of EMCN under inﬂammatory
conditions prevents neutrophil adhesion in vitro and reduces
the inﬁltration of CD45þ and NIMP-R14þ cells in vivo. These
data establish a critical role for EMCN in preventing leukocyte
adhesion within non-inﬂamed tissues, and indicate that
downregulation of EMCN during inﬂammation is necessary to
facilitate migration of inﬂammatory cells into targeted tissues.
Results
Venous and capillary endothelial cells express EMCN. EMCN
has been reported by us and others to localize to the luminal
surface of venous, but not arterial, endothelium19,20. The ciliary
body, which was examined in this study, is located in the anterior
segment of the eye, and consists of ciliary muscles and ciliary
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Figure 1 | Venous and capillary endothelium expresses EMCN in vivo. (a) Tissues were dissected from adult C5BL6 mice, ﬁxed in 4% paraformaldehyde,
frozen in optimal cutting temperature (O.C.T.) compound and cut into 10mm sections. EMCN localized to venules and capillaries of mouse ciliary bodies,
and co-localized with CD31þ endothelial cells in the ciliary body. Ciliary processes in the posterior chamber are indicated with arrowheads. Scale bar,
100mm. (b) In parafﬁn sections of normal human skin, EMCN (red) localized on the apical surface of venules marked by collagen IV (green). Nuclei were
counterstained using DAPI (blue). Scale bar, 50mm.
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processes, which contain fenestrated capillaries (Fig. 1a). In the
mouse ciliary body, capillaries stained strongly for EMCN;
notably, the staining co-localized with CD31þ endothelial cells.
The expression of EMCN in human tissues correlated with the
expression pattern in mice, and was observed on the apical
surface of the endothelial cells of skin venules (Fig. 1b). Taken
together, these results demonstrate the surface localization of
EMCN in venous and capillary endothelium, which is consistent
with previous reports19,20.
EMCN depletion leads to increased neutrophil interactions.
The apical localization of EMCN to venous endothelium suggests
a possible role in cell–cell interactions. To examine the function
of EMCN in vitro, a parallel-plate ﬂow chamber was utilized to
study the interactions between human neutrophils and human
umbilical vein endothelial cells (HUVECs) under shear stresses
that mimic those found in the postcapillary venous endothelium.
Loss of function was achieved on HUVECs under static
conditions using short interfering RNA (siRNA) to knockdown
EMCN gene expression. siRNA against EMCN led to more than
80% reduction in EMCN protein (Fig. 2a). As shown in Fig. 2b,
abrogation of EMCN led to a signiﬁcant increase in the number
of neutrophil–endothelial cell interactions at low shear stringency
(0.5–1.0 dynes per cm2), that was not observed in the
scramble siRNA control. These data demonstrate that under non-
inﬂammatory quiescent conditions, EMCN blocks neutrophil
interactions with the endothelium and in the absence of EMCN,
neutrophils can bind resting endothelial cells.
Since non-inﬂamed HUVECs constitutively express basal levels
of adhesion molecules, we examined whether knockdown of
EMCN affected expression of E-selectin, VCAM-1 and ICAM-1.
Flow cytometry analysis of these adhesion molecules revealed no
change in their expression after EMCN knockdown (Fig. 2c). The
higher level of ICAM-1 relative to E-selectin and VCAM-1 in
non-activated endothelial cells is consistent with previous
reports1,11. In light of these observations, we speculated that
the siRNA knockdown of EMCN was enabling neutrophil
interactions with the endothelium via the constitutively
expressed ICAM-1. To test this possibility, neutrophils were
pretreated with neutralizing monoclonal antibody (mAb) against
LFA-1 (20 mgml 1) or, as a negative control, anti-major
histocompatibility complex (anti-MHC) class I mAb, and then
allowed to interact under shear stress with HUVECs in which
EMCN had been knocked down. Results revealed that blocking
the interaction of neutrophils with ICAM-1 reduced neutrophil–
endothelial cell interactions by more than 60% at low shear stress
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Figure 2 | siRNA knockdown of EMCN leads to increased neutrophil–endothelial cell interactions. HUVECs seeded at 50% conﬂuence were transfected
with siRNA oligonucleotides targeted against EMCN. Analysis was performed 48 h after transfection on conﬂuent endothelial cell monolayers.
(a) siRNA led to a more than 80% knockdown of EMCN as determined by western blot in HUVECs. (b) Flow chamber studies revealed that at shear
stresses of 0.5–1.0 dynes per cm2 there was 46-fold increase in adhesion of neutrophils compared to scramble-treated HUVECs. Representative images
showing a freeze frame of neutrophils interacting with siScramble and siEMCN transfected HUVECs are shown. (c) Knockdown of EMCN did not alter the
expression of pro-adhesive molecules, E-selectin, VCAM-1 or ICAM-1, as measured by ﬂow cytometry. (d) Neutralizing antibody to LFA-1 reversed cell–cell
interactions (including rolling and adherent cells) in siEMCN-treated HUVECs. Values for siRNA in (a) are expressed as mean±s.e.m., and results are
representative of three independent experiments. Data in (c) represent one of the three independent experiments performed. In (b) and (d), results are
representative of two to three human donors, and ﬂow chamber experiments were performed in triplicate conditions, mean±s.e.m. Signiﬁcance was
determined for (a) using Student’s t-test or (b and d) using one-way ANOVA followed by Newman–Keuls post hoc test. *Po0.05, **Po0.01 and
***Po0.001; NS, nonsigniﬁcant. Scale bar, 50mm.
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stringency (Fig. 2d). We conclude that the binding of neutrophils
to constitutively expressed ICAM-1 on non-activated endothelial
cells is opposed by robust EMCN expression.
TNF-a suppresses EMCN expression. In light of the fact that
leukocyte recruitment and inﬁltration occurs primarily in
postcapillary venules during inﬂammation, we investigated the
effect of cytokine treatment on endothelial expression of EMCN
in vitro. Conﬂuent HUVECs were stimulated with TNF-a (10 or
25 ngml 1) for 4 and 24 h, and the expression of EMCN mRNA
and cell surface protein were assessed by quantitative real-time
PCR (qRT–PCR) and western blot analysis of biotinylated pro-
teins, respectively. TNF-a treatment of HUVECs led to a dose-
dependent decrease in EMCN mRNA at both 4 and 24 h (Fig. 3a).
Similarly, TNF-a treatment of HUVECs led to a 35% reduction at
4 h, and a 70% reduction at 24 h, of cell surface EMCN in a
dose-dependent manner (Fig. 3b). To account for variation in
cell number after treatment with TNF-a, quantitative data on
EMCN mRNA and cell surface protein levels were
normalized to housekeeping controls GAPDH and actin,
respectively. The TNF-a-induced reduction of EMCN was also
conﬁrmed by immunoﬂuorescence staining on HUVECs treated
by 10 ngml 1 TNF-a at 24 h (Fig. 3c). TNF-a as a potent
proinﬂammatory cytokine is also known to induce the expression
of the pro-adhesive molecules E-selectin, VCAM-1 and ICAM-1.
Shown by ﬂow cytometry, concomitant with the decrease of cell
surface EMCN, there was an increase in pro-adhesive molecules
ICAM-1, VCAM-1 and E-selectin, which reached maximal
levels at 24 h (Fig. 3d). These ﬁndings demonstrate an inverse
relationship between the expression of the anti-adhesive EMCN
and pro-adhesive molecules under inﬂammatory conditions.
In addition to TNF-a, treatment with IL-1b or IFN-g also led
to dose-dependent reduction of EMCN protein expression
(Supplementary Fig. 1), suggesting that EMCN downregulation
by inﬂammatory cytokines is a common feature of inﬂammation.
EMCN overexpression prevents neutrophil adhesion. To
further determine the extent to which EMCN can prevent
neutrophil–endothelial cell interactions, murine EMCN
(mEMCN) was overexpressed in HUVECs before their treatment
with TNF-a for 24 h. mEMCN overexpression was accomplished
by adenoviral transduction at multiplicity of infection (MOI) 6
for 48 h as demonstrated by western blot analysis (Fig. 4a).
Adenoviral transduction with mEMCN (Ad-EMCN) or green
ﬂuorescent protein (Ad-GFP) did not alter the biosynthesis of
pro-adhesive molecules, E-selectin, VCAM-1 and ICAM-1
(Fig. 4b). In addition, EMCN overexpression did not inﬂuence
TNF-a induction of ICAM-1.
Neutrophil–endothelial cell adhesion assays were performed to
determine whether mEMCN could prevent binding of neutro-
phils to endothelial cells, following treatment with TNF-a, which
triggers high levels of pro-adhesive molecules. Analysis using the
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Figure 3 | TNF-a inhibits EMCN expression in vitro. Conﬂuent HUVECs were treated with TNF-a (10 and 25 ngml 1) for 4 and 24 h after overnight
serum starvation. mRNA, biotinylated protein and ﬁxed cells were collected for analysis of (a) EMCN mRNA expression as determined by qRT–PCR
(relative expression of EMCN as compared with GAPDH mRNA levels); (b) cell surface EMCN as determined by western blot; and (c) localization and
quantiﬁcation of EMCN (10 ngml 1 for 24 h) ﬂuorescence intensity as determined by immunoﬂuorescence staining. Insets in (c) show corresponding
phase-contrast images. The effect of TNF-a on the expression of pro-adhesive molecules, ICAM-1, VCAM-1 and E-selectin (d) were determined by ﬂow
cytometry. TNF-a treatment led to reduction of EMCN mRNA, cell surface EMCN and total EMCN while it upregulated pro-adhesive molecules ICAM-1,
VCAM-1 and E-selectin. Values are expressed as mean±s.e.m. Data in (d) are plotted as percentage of max versus increasing ﬂuorescence intensity.
Results represent one of three independent experiments performed. Signiﬁcance was determined for (a and b) using two-way ANOVA with Bonferroni’s
post hoc test or (c) using Student’s t-test. *Po0.05, **Po0.01, ***Po0.001 and ****Po0.0001; CS, cell surface; NS, nonsigniﬁcant. Scale bar, 50mm.
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in vitro ﬂow chamber assay indicated that overexpression of
mEMCN signiﬁcantly blocked neutrophil adhesion to stimulated
HUVECs. Speciﬁcally, neutrophil adhesion to HUVECs over-
expressing mEMCN decreased by up to 70% at 0.5–1.0 dynes per
cm2 compared to control Ad-GFP-treated cells (Fig. 4c). These
ﬁndings demonstrate that mEMCN is able to prevent neutrophil
adhesion even after signiﬁcant upregulation of pro-adhesive
molecules by TNF-a. Noticeably, this suppression was achieved
by overexpressing mEMCN at MOI 6, by which total EMCN
protein level was comparable to the level seen in untreated
control (Supplementary Fig. 2). Lower level of EMCN over-
expression (at MOI 1 and 3) could not suppress TNF-a-induced
neutrophil adhesion. This result suggests that normalizing EMCN
protein to its physiological level is necessary for the suppression
of neutrophil adhesion.
To assess whether the expression of EMCN effects neutrophil
adhesion or transmigration, or both steps in stimulated HUVECs,
neutrophils under ﬂow chamber conditions were allowed to
accumulate on the endothelial surface that had been treated with
TNF-a (10 ngml 1) for 24 h. After the designated accumulation
time, the number of neutrophils transmigrating through the
endothelium were determined and are represented at %
transmigrated. EMCN overexpression did not prevent transmi-
gration of adherent neutrophils as compared to Ad-GFP
overexpressing HUVECs (Fig. 4d), indicating that EMCN is a
barrier to neutrophil adhesion, and does not inﬂuence cell
transmigration.
Role of EMCN in inﬂammation in vivo. To assess the con-
tribution of EMCN to neutrophil–endothelial cell interactions
in vivo, we injected the potent proinﬂammatory cytokine TNF-a
into the vitreous cavity of the eye to induce the inﬂux of
leukocytes. As a negative control, mice received a similar injection
of saline. To determine whether inﬁltration of leukocytes cells can
be altered by overexpression of EMCN, 7 days before the TNF-a
injection, mice received an intravitreal injection of either
Ad-EMCN, or Ad-GFP as a negative control.
As the primary site of leukocyte inﬁltration in the eye is
the ciliary body24, we ﬁrst investigated the time course of
TNF-a-induced inﬂammatory cell inﬁltration in ciliary body
vessels in situ. Flow cytometry was conducted on dissociated
ciliary body cells stained for CD45 (a pan-leukocyte marker) from
eyes collected 12, 24 and 48 h after TNF-a injection (Fig. 5a). At
12 and 24 h, TNF-a treatment led toB7-fold increase of CD45þ
cells compared to saline-injected controls at the same time points.
At 48 h, there was still a trend of increase in CD45þ cells but at a
lower level compared to 12 and 24 h. Second, the effects of TNF-a
on EMCN expression in ciliary body vessels were evaluated by
western blot (Fig. 5b; Supplementary Fig. 3). Consistent with our
in vitro ﬁndings, 24 h TNF-a treatment reduced the level of ciliary
body EMCN by B50% as compared to saline-injected controls
(Fig. 5b). Although the reduction of EMCN in ciliary body by
TNF-a was persistent at 48 h (Supplementary Fig. 3), the effect of
EMCN overexpression on inﬂammatory cell inﬁltration was
evaluated at 24 h given that the increase of CD45þ cells peaks
at 24 h.
Ad-EMCN or Ad-GFP as control was injected intravitreally
7 days before TNF-a injection. Adenoviral transduction of the
ciliary body vessels was conﬁrmed by co-localized expression of
GFP and endothelial cell marker using confocal microscopy
(Supplementary Fig. 4a), and by quantiﬁcation of CD31þ
GFPþ cells using ﬂow cytometry (Supplementary Fig. 4b).
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Figure 4 | Overexpression of EMCN protects endothelial cells from neutrophil adhesion induced by treatment with TNF-a. (a) Sub-conﬂuent HUVECs
were transduced for 48 h with adenoviruses expressing mEMCN (Ad-EMCN) at an MOI 6. Protein biosynthesis of mouse and human EMCN (hEMCN)
were determined by western blot. Transduction with GFP (Ad-GFP) at an MOI 6 was used as control. (b) After adenovirus transduction at MOI 6 and
TNF-a stimulation (10 ngml 1, 24 h), HUVECs were dissociated for evaluation of pro-adhesive molecules, E-selectin, VCAM-1 and ICAM-1, by ﬂow
cytometry. Expression of pro-adhesive molecules was unaffected by overexpression of Ad-GFP and Ad-EMCN. (c) Flow studies revealed that TNF-a
treatment of cells overexpressing mEMCN at an MOI 6 led to a reduced total number of neutrophil–endothelial cell interactions compared to control
Ad-GFP-transfected cells. (d) EMCN overexpression did not inﬂuence the transmigration of neutrophils that adhered to TNF-a-treated HUVEC surfaces
transfected with Ad-EMCN compared to control Ad-GFP-transfected cells. Results in (a and b) represent one of three independent experiments performed.
In (c and d), results are representative of three human donor experiments performed, with each independent study performed in triplicate or duplicate,
respectively. Results represent mean±s.e.m. Signiﬁcance was determined for (c) using one-way ANOVA followed by Newman–Keuls post hoc test or
(d) using Student’s t-test. **Po0.01 and ***Po0.001; NS, nonsigniﬁcant.
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Two inﬂammatory cell markers (NIMP-R14 for neutrophil and
F4/80 for monocyte/macrophage) were used in addition to CD45
to evaluate inﬂammatory cell inﬁltration. First, it was conﬁrmed
that TNF-a led to signiﬁcant increases of NIMP-R14þ , F4/80þ
and CD45þ cells in ciliary body 24 h post TNF-a injection
compared to saline-injected controls within the Ad-GFP groups
(Fig. 5c). With Ad-EMCN injection, however, TNF-a-triggered
increases in CD45þ cells and NIMP-R14þ cells were reduced by
B50 and B40%, respectively, compared to the group that
received both Ad-GFP and TNF-a, whereas there was no
signiﬁcant change in F4/80þ cells (Fig. 5c).
Discussion
Under normal, non-inﬂammatory conditions, the vascular
endothelium maintains an apical surface in which leukocytes
and platelets do not adhere. Once inﬂammation is initiated,
leukocyte trafﬁcking is coordinated by sequential adhesive
interactions between the blood leukocytes and endothelial cells25.
The prevailing paradigm is that circulating leukocytes localize
speciﬁcally at the inﬂammation site due to proinﬂammatory
cytokines that are produced and released by interstitial or
paracellular resident leukocytes, which leads to endothelial cell
activation. The endothelial glycocalyx is the primary site of the
rapid transition between non-adherent and adherent states, and a
vast array of adhesive molecules both on leukocytes and
endothelial cells has now been described6,8,26. The non-
inﬂammatory nature of the endothelial surface has been largely
ascribed to the absence of pro-adhesive receptors and the possible
presence of a functional anti-adhesive molecule has
not been investigated. The endothelium plays a major role in
regulating adhesiveness by providing a strong negative charge12
and exposing membrane proteins with glycosylation motifs that
have both anti-adhesive and pro-adhesive roles, such as members
of the CD34 family18. Here we have documented the biological
importance of an endothelial-speciﬁc sialomucin, EMCN, in
maintaining an anti-inﬂammatory endothelial cell surface.
Although previous studies22,27 have suggested an anti-adhesive
function for EMCN, our data reveals the biological importance of
EMCN localization and expression in the vascular endothelium
under normal and inﬂammatory conditions. siRNA knockdown
of EMCN led to a signiﬁcant increase in neutrophil–endothelial
cell adhesion under a range of physiologically relevant laminar
shear stresses. Flow cytometry analysis of HUVECs treated with
siRNA targeting EMCN demonstrated that this effect was due to
the depletion of EMCN and not to an increase in expression of
pro-adhesive molecules, as E-selectin, VCAM-1 and ICAM-1
were not by affected by the depletion of EMCN. ICAM-1, which
is involved in leukocyte ﬁrm adhesion during inﬂammation, is
constitutively expressed by HUVECs1,11 and was unchanged by
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Figure 5 | Overexpression of EMCN in vivo protects against TNF-a-induced inﬂammatory cell inﬁltrations. (a) Ciliary bodies were collected 12, 24 and
48 h post intravitreal injection of saline or TNF-a (10 ng per 1ml), as well as uninjected controls. Following cell dissociation from ciliary bodies, CD45þ cells
were stained and analysed by ﬂow cytometry. TNF-a led to a signiﬁcant increase of CD45þ cells at 12 and 24h when compared to saline controls.
Each sample was pooled from two eyes and three samples were evaluated for saline or TNF-a-injected group. (b) Ciliary bodies were collected from eyes
24h after intravitreal injection of TNF-a (10 ng per 1ml), saline or uninjected. Tissue lysates were processed for western blot, and analysed by ImageJ
software. TNF-a led to a signiﬁcant reduction of EMCN protein in ciliary bodies compared to saline-injected controls. Further, saline injections did not
signiﬁcantly change the levels of EMCN protein compared to uninjected controls. Each sample was pooled from two eyes and six samples were evaluated
for each group. The box and whisker plot show the 25 and 75 percentiles (box), the median and the minimum and maximum data values (whiskers).
(c) Eyes were injected intravitreally with Ad-EMCN or Ad-GFP, followed by TNF-a (10 ng per 1ml) or saline 7 days later. Ciliary bodies were collected 24h
post TNF-a injection, dissociated, stained for CD45, NIMP-R14 and F4/80 and analysed by ﬂow cytometry. TNF-a led to signiﬁcant increases of CD45þ ,
NIMP-R14þ and F4/80þ cells compared to saline-injected group with Ad-GFP injection; Ad-EMCN signiﬁcantly suppressed TNF-a-induced increase in
CD45þ and NIMP-R14þ cells compared to Ad-GFP-injected group. Each sample was pooled from two eyes and four to six samples were evaluated for
each group. Results are displayed as mean±s.e.m. Signiﬁcance was determined for (a) using two-way ANOVA with Bonferroni’s post hoc test or (b and c)
using one-way ANOVA with Tukey’s post hoc test. *Po0.05, **Po0.01 and ***Po0.001; NS, nonsigniﬁcant.
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siRNA against EMCN. In light of the known relative sizes and
conformation of EMCN (75–90 kDa; extended mucin-like
ectodomain) and ICAM-1 (90 kDa; multiple extracellular Ig-like
loops)28, we speculated that depletion of EMCN was unmasking
ICAM-1, and allowing neutrophil adhesion. The ability of
neutralizing mAb against LFA-1 on neutrophils to disrupt
neutrophil binding to ICAM-1 on HUVECs supported this
hypothesis and also demonstrated that the EMCN in the
endothelial cell glycocalyx, possibly by exposing negatively
charged O-glycans that provide charge repulsion and steric
hindrance, is critical to maintaining an anti-adhesive surface
under non-inﬂammatory conditions. Interestingly, in vivo studies
have shown EMCN localization to the luminal surface of venous
and capillary, but not arterial, endothelium19,20. In vitro, however,
EMCN expression has been observed in human aortic and
microvascular endothelial cells29. These data suggest that laminar
shear stress may play an important role in regulating EMCN
expression, since expression of EMCN in the cell lines was
determined under static conditions, whereas the reported absence
of EMCN in arterial endothelium was in tissue where shear stress
is present. This hypothesis is supported by data indicating that
prolonged exposure to high shear stress downregulates expression
and surface localization of EMCN in HUVECs (Supplementary
Fig. 5). Taken together, our observations are consistent with the
idea that the glycocalyx provides a ﬁrst line of defence against
leukocyte adhesion and furthermore, support a role for EMCN in
limiting access of leukocytes to cell surface adhesion molecules.
EMCN has been shown to include the MECA-79 carbohydrate
epitope that is important in L-selectin-mediated interactions21.
Previous work has suggested that EMCN supports L-selectin-
mediated rolling, and is thus a pro-adhesive molecule30. However,
the data to support this conclusion were generated using CHO
cells overexpressing EMCN along with a speciﬁc combination
of carbohydrate modifying enzymes, glycosyltransferases and
sulfotransferases, which generates L-selectin-reactive capping
group in core-2 branched O-glycans attached to sialomucin
core proteins, such as EMCN. Thus, this experimental system that
was used to demonstrate that EMCN supports L-selectin-
mediated rolling along glass capillaries coated with a
neutralizing anti-L-selectin mAb appears unlikely to be relevant
to the endothelium in vivo.
Given the critical role of EMCN in maintaining a non-
inﬂammatory phenotype, we investigated its expression under
inﬂammatory conditions. A primary focus in the study of
inﬂammation has been on the promotion of leukocyte recruit-
ment and extravasation, and much less is known about the
potential contribution of anti-adhesive molecules. Previous
studies have shown that components of the glycocalyx, including
heparan sulfate and chondroitin sulfate, are shed in response
to injury or cytokine-mediated inﬂammation13–15. Thus, we
speculated that EMCN levels would be reduced in response to
TNF-a. In agreement with this notion, we found that TNF-a
treatment of HUVECs led to a decrease in EMCN mRNA and
surface protein, and an increase in the pro-adhesive molecules
E-selectin, VCAM-1 and ICAM-1. A potential mechanism of
EMCN downregulation by TNF-a is likely to involve binding to
the membrane receptors TNF-R55 and TNF-R75. TNF-R55 is
primarily responsible for the stimulation of leukocyte adhesion to
the endothelium by upregulation of adhesion molecules on the
endothelial cell surface31, but the role of these membrane
receptors in the downregulation of EMCN has not been yet
examined. TNF-a is also known to control the activation of
GATA-2 (ref. 32), a key transcription factor commonly expressed
in endothelial cells. Since GATA-2 elements are present in EMCN
gene regulatory sequences33, it is tempting to speculate a potential
role for GATA-2 in modulating EMCN expression under
proinﬂammatory conditions. Contrary to our results, a previous
study has reported increased EMCN expression upon TNF-a
treatment29. It is difﬁcult, however, to draw conclusions from this
study, since results were shown in sparse culture conditions,
which demonstrated signiﬁcant variability in the basal level of
EMCN expression, protein levels were not shown, and the
authors did not determine the statistical signiﬁcance of the data.
Motivated by the concept that the endothelial cell glycocalyx
has the capacity to prevent leukocyte adhesion to constitutively
expressed ICAM-1, we assessed the ability of EMCN to interfere
with the pro-adhesive effects of TNF-a. To accomplish this, we
treated HUVECs that were overexpressing EMCN with TNF-a
and examined neutrophil adhesion. Remarkably, overexpression
of EMCN prevented neutrophil adhesion to TNF-a stimulated
HUVECs under a range of physiologically relevant shear stresses.
Given the accessibility of the eye for study and the fact
that several ocular pathologies, including uveitis34,35, diabetic
retinopathy36,37 and glaucoma35, have inﬂammatory components,
we generated ocular inﬂammation to assess the role of EMCN
in vivo, and examined the level of EMCN protein in the ciliary
body, the primary site of neutrophil inﬁltration during intraocular
inﬂammation. Consistent with our in vitro observations,
intravitreal injection of TNF-a led to decreased of EMCN in the
ciliary body within 24h of treatment. Importantly, overexpression
of EMCN dramatically reduced the accumulation of CD45þ cells
as well as neutrophils (NIMP-R14þ cells) in the ciliary body
following TNF-a injection. On the basis of the results in this
experimental model, it is tempting to speculate that promoting
expression of EMCN to physiological levels would prevent
neutrophil extravasation into inﬂamed tissue, but this question
still remains unanswered in vivo. Overall, our observations
introduce the novel paradigm that the downregulation of anti-
adhesive molecules may be as important in transforming the
endothelial cell surface to a proinﬂammatory state as the elevation
in adhesive molecules. Moreover, our in vivo results provide an
exciting new therapeutic option for the manipulation of the
inﬂammatory process.
Methods
Mice. C57BL/6 female mice, 6–8 week in age, were purchased from Jackson
Laboratories (Bar Harbor, Maine). Mice were handled in accordance to the
National Institute of Health Guide for the Care and Use of Laboratory Animals.
All procedures were approved by the Institutional Animal Care and Use
Committee of the Schepens Eye Research Institute/Mass Eye and Ear.
Reagents and antibodies. Recombinant human TNF-a was purchased from
Pepro Tech. Blocking mAb against b2 integrin (TS1/18) and MHC class I mAb
(W6/32) were purchased from American Type Culture Collection (ATCC).
The following primary antibodies were used: rat anti-human EMCN (1:1,000,
ab45771, Abcam), rat anti-mouse EMCN V.7C7 (1:1,000, sc-65495, Santa Cruz
Biotechnology), mouse anti-actin (1:1,000, Santa Cruz Biotechnology), mouse
anti-tubulin (1:2,000, CalBiochem) and rabbit anti-GAPDH (1:1,000, Santa Cruz
Biotechnology). Antisera against human E-selectin (clone CL2), VCAM-1
(clone E1/6) and ICAM-1 (clone Hu 5/3) were purchased from ATCC. CD31 was
detected using rat anti-mouse CD31 (1:250, BD Pharmingen). For ﬂow cytometry
of cells from ciliary body, PE-NIMP-R14 (Novus), Brilliant Violet 421 anti-CD45
and PE-Cy7 anti-F4/80 (Biolegend) and PE-CD31 (BD Pharmingen) or their
corresponding isotype controls were used.
Cell culture. Primary HUVECs (provided by the Center for Excellence in Vascular
Biology, Brigham and Women’s Hospital, Boston, MA) were cultured on 0.1%
gelatin coated T-75 ﬂasks in EGM-2 medium (EBM-2, SingleQuots including
VEGF, Lonza) supplemented with 20% fetal bovine serum (FBS), L-glutamine, and
penicillin/streptomycin. For all experiments, HUVECs between passage 1 and 4
were used. Where indicated, conﬂuent HUVECs were treated with TNF-a (10 and
25 ngml 1) for 4 and 24 h. Cells were cultured for 12 h in medium (EBM-2, 0.5%
FBS, 25mM HEPES, penicillin/streptomycin) prior being subject to TNF-a
treatments.
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Leukocyte isolation. The leukocyte isolation protocol used in this study was
approved by Brigham and Women’s Institutional Review Board. Informed consent
was obtained from all volunteers. Blood was drawn from healthy adult donors.
Neutrophils were prepared from heparinized peripheral blood by density
sedimentation in a discontinuous gradient of Ficoll and Histopaque-1119. Care was
taken to minimize physical disruption or temperature changes to the neutrophil
preparation. Neutrophils were suspended at 5 105 cells per ml in Dulbecco’s PBS
containing 0.2% human serum albumin.
Flow apparatus design and application. The parallel-plate ﬂow chamber used in
the present study has been described previously in detail38. Brieﬂy, the ﬂow
chamber consists of two stainless steel plates separated by a silastic gasket. The
lower plate has a circular cutout where a glass coverslip coated with an endothelial
cell monolayer is placed. Fluid is then drawn through the chamber at deﬁned ﬂow
rates using a syringe pump. In our experiments, HUVEC monolayers were grown
on 25-mm glass coverslips coated with 5 mgml 1 ﬁbronectin (Sigma). In TNF-a
treated samples, HUVEC monolayers were incubated with 10 ngml 1 TNF-a for
24 h before the assay was performed. The coverslip was positioned into the ﬂow
chamber and the entire chamber was mounted on an inverted microscope.
Neutrophils were drawn through the chamber at an estimated shear stress of 1.5
dynes per cm2 for 2min, and then decreased by 0.5 dynes per cm2 every 2min to
0.5 dynes per cm2. Cells were pre-exposed to each laminar shear stress condition
for 1min before recording neutrophil adhesion for another min. Interactions were
recorded with a phase-contrast objective ( 20), and a video microscope connected
to Videolab software (Ed Marcus Laboratories, Boston, MA). The number of
neutrophil–EC interactions, including rolling and ﬁrmly adhered neutrophils, was
counted in six different ﬁelds after an initial min at each ﬂow rate39,40. For blocking
experiments, neutrophils, 0.5 106 cells per ml were incubated with mAbs
(TS1/18, W6/32), at 20mgml 1 for 30min at 4 C.
Neutrophil transmigration. The live-cell ﬂuorescence microscopy ﬂow model has
been described previously41. HUVEC monolayers on coverslips were activated with
TNF-a (10 ngml 1, 24 h) and inserted into the ﬂow chamber. Neutrophils
(1 106 per ml) were drawn across HUVECs at 1.0 dynes per cm2 and adhesion
and transmigration monitored by time-lapse, live-cell microscopy performed on a
Nikon-TE-200 microscope equipped with a  20 objective and a heating stage
maintained at 37 C. Differential interference contrast (DIC) optics was used to
visualize neutrophil transmigration.
Western blotting. Cells in culture were collected and lysed in RIPA buffer (Sigma,
USA) containing protease (Complete, Mini, EDTA-free; Roche) and phosphatase
inhibitors (phosphatase inhibitor cocktails 2, Sigma) at 4 C for 5min. Protein
concentrations were determined using the BCA protein assay kit (Pierce) after
three cycles of freeze thaw. For protein collected from tissues, the ciliary bodies
from two eyes were pooled and disrupted in lysis buffer (Cell Signaling Technology,
MA) containing protease (Complete, Mini, EDTA-free; Roche) and phosphatase
inhibitors (phosphatase inhibitor cocktails 2, Sigma, USA), and exposed to high
frequency ultra-sonication. Equal amounts of protein (10–50 mg for cell lysate, and
3–5 mg for tissue lysate) were separated by SDS–polyacrylamide gel electrophoresis
(10% acrylamide) under reducing conditions and transferred to PVDF membranes
(Immobilon-P, Millipore). Membranes were blocked in 1 TBS containing 0.1%
Tween, 5% non-fat milk and 2.5% BSA for 1 h, and then probed with primary
antibody overnight at 4 C. Secondary antibody incubations were performed
with the corresponding horseradish peroxidase-conjugated antibody at room
temperature for 1 h. Proteins were detected by chemiluminescence with
SuperSignal West Pico or Dura (Thermo Scientiﬁc).
Biotinylation of cell surface proteins. To determine the presence and relative
protein levels of EMCN on the endothelial cell membrane, cell surface proteins
were biotinylated and isolated by chromatography on a NeutrAvidin-agarose
afﬁnity column using Pinpoint cell surface protein isolation kit (Pierce, Rockford,
IL), according to the manufacturer’s instructions. Membrane extracts of the
labelled cells were analysed for the presence of EMCN by western blot, as described
above.
RNA isolation and real-time PCR analysis. RNA was collected from HUVECs in
TRIzol and extracted according to manufacturer’s instructions. DNase treatment
was performed using DNase 1 from Ambion (cat# AM2224). First-strand cDNA
was synthesized from 1 mg of total RNA with oligo(dT)20 primer and reverse
transcriptase (iScript, Bio-Rad Laboratories, USA) in a 25-ml reaction, following the
manufacturer’s protocol. For real-time PCR, reactions were performed on the ABI
Prism 97000 Sequence Detection System (Applied Biosystems) using 5 ml of cDNA,
1 ml of 10mM forward and reverse primer, 12.5 ml SYBR Green PCR master mix
(Applied Biosystems) and 5.5 ml of H2O, according to the manufacturer’s
instructions. Ampliﬁcation of GAPDH was performed on each sample as a control
for normalization.
EMCN: forward (50-ATTTGTTCTGGTGGGTTTGT-30)
Reverse (50-TGCAGGACTTTCTCCTTTTC-30)
GAPDH: forward (50-CCCATCACCATCTTCCAGGA-30)
Reverse (50-CATCGCCCCACTTGATTTTG-30)
siRNA knockdown. HUVECs were seeded at 50% conﬂuence 1 day before
transfection. Cells were washed with 1 PBS to remove residual antibiotics and
equilibrated in OPTI-MEM. siRNA against EMCN (siRNA EMCN #3 AS00KOXP,
cat# 4399665, ID S229102) or the control siRNA (Ambion: 50mM stock solution)
were incubated with Oligofectamine (Invitrogen) 1:4 ratio in OPTI-MEM at room
temperature for 20min to form complexes, then added to cells at a ﬁnal siRNA
concentration of 200 nmolml 1. After 6 h, complete growth medium without
antibiotics and VEGF was added to the cells. After 24 h, cells were placed into
normal growth medium. Proteins were collected after 48 h of transfection.
Histological analysis and microscopy. Tissues were dissected from adult mice
that were anesthetized with ketamine/xylazine and PBS-perfused via the aorta.
After overnight ﬁxation at 4 C with 4% paraformaldehyde in PBS, tissues were
washed with PBS, and cryoprotected in 20% sucrose. Tissues were then inﬁltrated
overnight at 4 C and embedded the next day with the same 2:1 mixture of 20%
sucrose and O.C.T. compound before being frozen on dry ice.
For identiﬁcation of vascular cell type, tissue sections were subjected to
immunoperoxidase staining. After washing with PBS and permeabilization with
PBS containing 0.2% Tween 20 (PBST), endogenous peroxidase activity was
blocked by incubation with 1% H2O2 in PBS for 10min. Non-speciﬁc binding was
blocked by incubation with blocking buffer (3% rabbit serum in PBST) for 30min
at room temperature. Tissue sections were incubated with either rat anti-mouse
CD31 (1:250, BD Pharmingen) or rat anti-mouse EMCN (1:1,000, mAb V.7C7,
Santa Cruz) diluted in blocking buffer overnight at 4 C. A section incubated
with rat IgG as a negative control was included in each experiment. Slides were
examined and images were captured using a Zeiss Axioskop 2 MOT microscope
with a mounted AxioCam digital camera under both  20 and  40 objective
lenses. Post-acquisition processing of images was conducted using Adobe
Photoshop.
Immunoﬂuorescence. A biopsy of healthy human skin of a 72-year-old female
was obtained with informed consent, following an approval of the Human Studies
Committee at Schepens Eye Research Institute/Massachusetts Eye and Ear. The
biopsy was ﬁxed in 4% paraformaldehyde in PBS at room temperature for 24 h. The
tissue was embedded in parafﬁn, sectioned and processed by standard techniques.
The rehydrated tissue sections were treated with Vector-Antigen UnMasking
solution for 20min followed by pretreatment with sodium borohydrate 0.1% in
PBS for 5min. The sections were then washed in 1 PBS and blocked for 1 h at
room temperature in 3% goat serum, 3% donkey serum, 2.5% BSA, 0.2% Tween 20.
Immunoﬂuorescent staining for EMCN and collagen IV was performed using
monoclonal rat anti-human EMCN (1:1,000, Abcam) and mouse anti-human
collagen-IV (1:500, Sigma) overnight at 4 C. Secondary DyLight 550-conjugated
goat anti-rat (1:300, Abcam) and Alexa Fluor 488-conjugated goat anti-mouse
(1:300, Invitrogen) antibodies, and 4,6-diamidino-2-phenylindole (DAPI) for cell
nucleus, were used and incubated for 45min at room temperature. For each
experiment, a section was incubated with isotype-matched IgG as a negative
control.
For localization of EMCN in cell culture, HUVECs grown on ﬁbronectin treated
glass coverslips were ﬁxed in 1% formalin at 4 C overnight, permeabilized with
0.01% Triton X-100 in PBS, washed three times for 5min in 1 PBS, and blocked
with 3% secondary serum species, 1% BSA for 1 h at room temperature. Coverslips
were then incubated in rat anti-human EMCN Ab (1:500, Abcam) at 4 C
overnight, followed by 3 5min washes in 1 PBS. The cells were then incubated
in the secondary ﬂuorescent antibodies (DyLight 550) for 1 h at room temperature
and washed in 1 PBS. Fluorescent images were taken with Zeiss Fluorescent
Microscope (Axioskop 2 MOT Plus,  40 objective). Analysis of EMCN
ﬂuorescence intensity was performed using ImageJ software (National Institutes of
Health, Bethesda, MD). Fluorescence intensity was measured in two different spots
of each endothelial cell in 40 different cells in images corresponding to two
different experiments and two different ﬁelds of view. Values were normalized by
dividing each by the average value corresponding to EMCN ﬂuorescence intensity
in control cells.
Flow cytometry. For cultured cells, HUVECs were detached non-enzymatically
using cell-dissociation buffer (Gibco), collected by centrifugation 1,000g for 5min,
washed two times with cold 1 PBS and ﬁxed in 1% formaldehyde for 30min at
room temperature, followed by three washes in 1 PBS. Cells (1 106 per ml)
were treated with the indicated mAb to ICAM-1, VCAM-1 and E-selectin
(1:50, ATCC) for 20min on ice, followed by incubation with ﬂuorescein
isothiocyanate or phycoerythrin (PE)-conjugated goat anti-mouse antibody (1:50)
on ice for 30min. Cell surface levels were analysed using a FACSCalibur (Becton
Dickinson). Histograms of per cent max versus ﬂuorescence (FL1-4) were plotted
on the y and x axis, respectively.
For ciliary body tissue, samples were digested with collagenase IV
(1,000Uml 1, Worthington) and DNase I (1Uml 1, Sigma) in PBS at 37 C for
1 h. Cells were then dissociated by gentle pipetting and collected after ﬁltering
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through 70 mm cell strainers (BD). After wash, cells were divided equally into two
tubes for each antibody and its isotype control, or into three tubes to include
unstained control. Cells were blocked with 1% BSA in PBS for 10min and stained
with directly conjugated antibodies: PE-NIMP-R14 (Novus), Brilliant Violet 421
anti-CD45 and PE-Cy7 anti-F4/80 (Biolegend) or their corresponding isotype
controls for 30min at 4 C. After wash, cells were resuspended in 500 ml 1% BSA in
PBS, and cell ﬂuorescence was measured by using a BD LSR II ﬂow cytometer.
Data were acquired until 200,000 events were collected. Cells from the
Ad-GFPþTNF-a group were stained with each antibody and its isotype control,
then analysed by ﬂow cytometry to set up the compensation. Data analysis was
performed using FlowJo, and results represented as the percentage of positive cells
after compensation and correction using isotype controls.
EMCN adenovirus production and transduction. A cDNA encoding full-length
mEMCN (provided by Dietmar Vestweber, Division of Vascular Cell Biology,
Max-Planck-Institute, Germany) was cloned into a pShuttle vector using standard
molecular biology techniques. Clones containing the EMCN cDNA were ampliﬁed
in DH5a cells, linearized and dephosphorylated. The linearized plasmid was
co-transformed with the pAdEasy vector (Stratagene) into BJ5183 cells to produce
recombinant adenoviral plasmid through homologous recombination. Enhanced
GFP (EGFP) was similarly cloned into pAdEasy as a control. The engineered
adenoviral vectors were ampliﬁed in DH5a cells and puriﬁed using Maxiprep
plasmid puriﬁcation columns (Qiagen). Puriﬁed adenoviral plasmids were linear-
ized and transfected into 293A cells. Virus was ampliﬁed from a single plaque by
serial transduction onto 15 cm2 plates of 293A cells and puriﬁed by two cycles of
CsCl gradients. Puriﬁed virus was veriﬁed by restriction digest and sequence
analysis of viral DNA from both preparations. The ﬁnal products were tittered by
optical absorbance methods. The result was converted and expressed as plaque
forming units (p.f.u.) per ml. The EMCN adenovirus titre was 3.1 1010 p.f.u.ml 1
and EGFP adenovirus titre 1 1011 p.f.u. ml 1. The virus was distributed in the
following formulation: 50mM Tris-HCl (pH 7.4), 5mM EDTA, 1.4 M CsCl,
50mM NaCl, 0.5mM MgCl2 and 25% glycerol. Virus production, puriﬁcation,
veriﬁcation and tittering were performed by the Harvard Gene Therapy Initiative,
Boston, MA. HUVECs were seeded at 50% conﬂuence 1 day before adenoviral
transduction. Sub-conﬂuent cells were transduced with Ad-GFP or Ad-EMCN at
an MOI 6 for 48 h in normal growth medium, cells were thereafter washed with
1 PBS and processed for protein. For the experiments in which cells were
stimulated with TNF-a, the cells were ﬁrst transduced with the adenoviruses
for 24 h and then treated with TNF-a (10 ngml 1) and processed for protein
24 h later.
Intravitreal injections. Mice were anesthetized by intraperitoneal injection of a
mixture of ketamine–xylazine (100mg kg 1 ketamine/20mg kg 1 xylazine body
weight). By using a 30-G hypodermic needle, an incision was made just posterior to
the limbal vessels. A coverslip was used to applanate the cornea to allow view to the
posterior pole of the eye. Injections were performed using a Hamilton syringe ﬁtted
with a 33-G needle placed directly above the optic nerve head. Mice received an
intravitreal injection of TNF-a (Millipore/Chemicon, 10 ng in 1 ml saline) or as a
negative control, 1 ml injection of saline only. Ciliary bodies from two eyes were
pooled and collected at designated time points post TNF-a injection to determine
EMCN protein levels by western blot analysis or inﬂammatory cell inﬁltration by
ﬂow cytometry. Overexpression of EMCN was achieved by intravitreal injection of
Ad-EMCN (3.1 107 p.f.u. ml 1) 7 days before TNF-a injection, with Ad-GFP
injection (3.1 107 p.f.u. ml 1) as controls. Slit lamp examination was conducted
before TNF-a injection, and mice that displayed signs of inﬂammation (clouding of
the anterior or posterior chamber) were excluded from the study.
Statistics. Statistical analysis was carried out with Prism 4.0b for Macintosh.
All data are shown as mean±s.e.m. The mean values from each group were
compared by Student’s t-test, one-way analysis of variance (ANOVA) with Tukey’s
post hoc test, one-way ANOVA followed by Newman–Keuls post hoc test or
two-way ANOVA with Bonferroni’s post hoc test. In all tests, P values o0.05
were considered statistically signiﬁcant.
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